| Authors: |
Dominguez Islas CP; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Magaret CA; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Molitor C; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA., Serebryannyy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Castro M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Posavad CM; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Atmar RL; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA., Janes H; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. Electronic address: hjanes@fredhutch.org., Deming ME; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. |
